Yutaka Kawakami - Publications

Affiliations: 
Keio University, Minato-ku, Tōkyō-to, Japan 

93 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Tamura R, Morimoto Y, Kosugi K, Sato M, Oishi Y, Ueda R, Kikuchi R, Nagashima H, Noji S, Kawakami Y, Sasaki H, Yoshida K, Toda M. Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case series. Bmc Cancer. 20: 196. PMID 32164575 DOI: 10.1186/s12885-020-6589-x  0.72
2020 Kawakami Y, Ohta S, Sayem MA, Tsukamoto N, Yaguchi T. Immune-resistant mechanisms in cancer immunotherapy. International Journal of Clinical Oncology. PMID 31919690 DOI: 10.1007/s10147-019-01611-x  0.48
2019 Tamura R, Fujioka M, Morimoto Y, Ohara K, Kosugi K, Oishi Y, Sato M, Ueda R, Fujiwara H, Noji S, Oishi N, Ogawa K, Kawakami Y, Ohira T, Yoshida K, et al. A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2. Nature Communications. 10: 5758. PMID 31848332 DOI: 10.1038/s41467-019-13640-1  0.72
2019 Hirao N, Iwata T, Tanaka K, Nishio H, Nakamura M, Morisada T, Morii K, Maruyama N, Katoh Y, Yaguchi T, Ohta S, Kukimoto I, Aoki D, Kawakami Y. Transcription factor homeobox D9 is involved in the malignant phenotype of cervical cancer through direct binding to the human papillomavirus oncogene promoter. Gynecologic Oncology. PMID 31477279 DOI: 10.1016/j.ygyno.2019.08.026  0.48
2019 Kikuchi R, Ueda R, Saito K, Shibao S, Nagashima H, Tamura R, Morimoto Y, Sasaki H, Noji S, Kawakami Y, Yoshida K, Toda M. A Pilot Study of Vaccine Therapy with Multiple Glioma Oncoantigen/Glioma Angiogenesis-Associated Antigen Peptides for Patients with Recurrent/Progressive High-Grade Glioma. Journal of Clinical Medicine. 8. PMID 30791546 DOI: 10.3390/jcm8020263  0.72
2018 Mukai S, Ogawa Y, Saya H, Kawakami Y, Tsubota K. Therapeutic potential of tranilast for the treatment of chronic graft-versus-host disease in mice. Plos One. 13: e0203742. PMID 30307955 DOI: 10.1371/journal.pone.0203742  0.36
2018 Shibao S, Ueda R, Saito K, Kikuchi R, Nagashima H, Kojima A, Kagami H, Pareira ES, Sasaki H, Noji S, Kawakami Y, Yoshida K, Toda M. A pilot study of peptide vaccines for VEGF receptor 1 and 2 in patients with recurrent/progressive high grade glioma. Oncotarget. 9: 21569-21579. PMID 29765561 DOI: 10.18632/oncotarget.25131  0.72
2018 Kamamoto D, Ohara K, Kitamura Y, Yoshida K, Kawakami Y, Sasaki H. Association between programmed cell death ligand-1 expression and extracranial metastasis in intracranial solitary fibrous tumor/hemangiopericytoma. Journal of Neuro-Oncology. PMID 29675794 DOI: 10.1007/s11060-018-2876-7  0.4
2017 Nakamura K, Yaguchi T, Ohmura G, Kobayashi A, Kawamura N, Iwata T, Kiniwa Y, Okuyama R, Kawakami Y. Involvement of local renin-angiotensin system in immunosuppression of tumor microenvironment. Cancer Science. PMID 29034589 DOI: 10.1111/cas.13423  0.36
2017 Ohta S, Kawakami Y, Okano H. MIF: functions in brain and glioblastoma. Oncotarget. PMID 28636550 DOI: 10.18632/oncotarget.18489  0.48
2017 Saito K, Ohta S, Kawakami Y, Yoshida K, Toda M. Functional analysis of KIF20A, a potential immunotherapeutic target for glioma. Journal of Neuro-Oncology. PMID 28070829 DOI: 10.1007/s11060-016-2360-1  0.72
2016 Ohta S, Yaguchi T, Okuno H, Chneiweiss H, Kawakami Y, Okano H. CHD7 promotes proliferation of neural stem cells mediated by MIF. Molecular Brain. 9: 96. PMID 27955690 DOI: 10.1186/s13041-016-0275-6  0.48
2016 Fukaya R, Ohta S, Yaguchi T, Matsuzaki Y, Sugihara E, Okano H, Saya H, Kawakami Y, Kawase T, Yoshida K, Toda M. MIF maintains the tumorigenic capacity of brain tumor-initiating cells by directly inhibiting p53. Cancer Research. PMID 26980763 DOI: 10.1158/0008-5472.CAN-15-1011  0.72
2016 Matsushita M, Otsuka Y, Tsutsumida N, Tanaka C, Uchiumi A, Ozawa K, Suzuki T, Ichikawa D, Aburatani H, Okamoto S, Kawakami Y, Hattori Y. Identification of Novel HLA-A*24:02-Restricted Epitope Derived from a Homeobox Protein Expressed in Hematological Malignancies. Plos One. 11: e0146371. PMID 26784514 DOI: 10.1371/journal.pone.0146371  0.72
2015 Yamaguchi SI, Ueki A, Sugihara E, Onishi N, Yaguchi T, Kawakami Y, Horiuchi K, Morioka H, Matsumoto M, Nakamura M, Muto A, Toyama Y, Saya H, Shimizu T. Synergistic antiproliferative effect of imatinib and adriamycin in platelet-derived growth factor receptor-expressing osteosarcoma cells. Cancer Science. 106: 875-82. PMID 25940371 DOI: 10.1111/cas.12686  0.72
2015 Namiki T, Yaguchi T, Nakamura K, Valencia JC, Coelho SG, Yin L, Kawaguchi M, Vieira WD, Kaneko Y, Tanemura A, Katayama I, Yokozeki H, Kawakami Y, Hearing VJ. NUAK2 Amplification Coupled with PTEN Deficiency Promotes Melanoma Development via CDK Activation. Cancer Research. 75: 2708-15. PMID 25832654 DOI: 10.1158/0008-5472.CAN-13-3209  0.72
2015 Katano I, Takahashi T, Ito R, Kamisako T, Mizusawa T, Ka Y, Ogura T, Suemizu H, Kawakami Y, Ito M. Predominant development of mature and functional human NK cells in a novel human IL-2-producing transgenic NOG mouse. Journal of Immunology (Baltimore, Md. : 1950). 194: 3513-25. PMID 25712215 DOI: 10.4049/jimmunol.1401323  0.72
2015 Mayanagi S, Kitago M, Sakurai T, Matsuda T, Fujita T, Higuchi H, Taguchi J, Takeuchi H, Itano O, Aiura K, Hamamoto Y, Takaishi H, Okamoto M, Sunamura M, Kawakami Y, et al. Phase I pilot study of Wilms tumor gene 1 peptide-pulsed dendritic cell vaccination combined with gemcitabine in pancreatic cancer. Cancer Science. 106: 397-406. PMID 25614082 DOI: 10.1111/cas.12621  0.72
2015 Ohmura G, Tsujikawa T, Yaguchi T, Kawamura N, Mikami S, Sugiyama J, Nakamura K, Kobayashi A, Iwata T, Nakano H, Shimada T, Hisa Y, Kawakami Y. Aberrant Myosin 1b Expression Promotes Cell Migration and Lymph Node Metastasis of HNSCC. Molecular Cancer Research : McR. 13: 721-31. PMID 25421751 DOI: 10.1158/1541-7786.MCR-14-0410  0.72
2015 Iwata T, Fujii T, Morii K, Saito M, Sugiyama J, Nishio H, Morisada T, Tanaka K, Yaguchi T, Kawakami Y, Aoki D. Cytokine profile in cervical mucosa of Japanese patients with cervical intraepithelial neoplasia. International Journal of Clinical Oncology. 20: 126-33. PMID 24578180 DOI: 10.1007/s10147-014-0680-8  0.72
2014 Fujita Y, Okamoto M, Goda H, Tano T, Nakashiro K, Sugita A, Fujita T, Koido S, Homma S, Kawakami Y, Hamakawa H. Prognostic significance of interleukin-8 and CD163-positive cell-infiltration in tumor tissues in patients with oral squamous cell carcinoma. Plos One. 9: e110378. PMID 25461761 DOI: 10.1371/journal.pone.0110378  0.72
2014 Hazama S, Takenouchi H, Tsunedomi R, Iida M, Suzuki N, Iizuka N, Inoue Y, Sakamoto K, Nakao M, Shindo Y, Kanekiyo S, Tokumitsu Y, Yoshimura K, Maeda N, Maeda K, ... ... Kawakami Y, et al. Predictive biomarkers for the outcome of vaccination of five therapeutic epitope peptides for colorectal cancer. Anticancer Research. 34: 4201-5. PMID 25075047  0.72
2014 Saito K, Iizuka Y, Ohta S, Takahashi S, Nakamura K, Saya H, Yoshida K, Kawakami Y, Toda M. Functional analysis of a novel glioma antigen, EFTUD1. Neuro-Oncology. 16: 1618-29. PMID 25015090 DOI: 10.1093/neuonc/nou132  0.72
2014 Hazama S, Nakamura Y, Tanaka H, Hirakawa K, Tahara K, Shimizu R, Ozasa H, Etoh R, Sugiura F, Okuno K, Furuya T, Nishimura T, Sakata K, Yoshimatsu K, Takenouchi H, ... ... Kawakami Y, et al. A phase ΙI study of five peptides combination with oxaliplatin-based chemotherapy as a first-line therapy for advanced colorectal cancer (FXV study). Journal of Translational Medicine. 12: 108. PMID 24884643 DOI: 10.1186/1479-5876-12-108  0.72
2014 Kawamura N, Udagawa M, Fujita T, Sakurai T, Yaguchi T, Kawakami Y. Intratumoral injection of BCG-CWS-pretreated dendritic cells following tumor cryoablation. Methods in Molecular Biology (Clifton, N.J.). 1139: 145-53. PMID 24619677 DOI: 10.1007/978-1-4939-0345-0_13  0.72
2014 Kudo-Saito C, Yura M, Yamamoto R, Kawakami Y. Induction of immunoregulatory CD271+ cells by metastatic tumor cells that express human endogenous retrovirus H. Cancer Research. 74: 1361-70. PMID 24590808 DOI: 10.1158/0008-5472.CAN-13-1349  0.72
2014 Nakamura S, Yaguchi T, Kawamura N, Kobayashi A, Sakurai T, Higuchi H, Takaishi H, Hibi T, Kawakami Y. TGF-β1 in tumor microenvironments induces immunosuppression in the tumors and sentinel lymph nodes and promotes tumor progression. Journal of Immunotherapy (Hagerstown, Md. : 1997). 37: 63-72. PMID 24509168 DOI: 10.1097/CJI.0000000000000011  0.72
2014 Galon J, Mlecnik B, Bindea G, Angell HK, Berger A, Lagorce C, Lugli A, Zlobec I, Hartmann A, Bifulco C, Nagtegaal ID, Palmqvist R, Masucci GV, Botti G, Tatangelo F, ... ... Kawakami Y, et al. Towards the introduction of the 'Immunoscore' in the classification of malignant tumours. The Journal of Pathology. 232: 199-209. PMID 24122236 DOI: 10.1002/path.4287  0.72
2013 Ohta S, Misawa A, Lefebvre V, Okano H, Kawakami Y, Toda M. Sox6 up-regulation by macrophage migration inhibitory factor promotes survival and maintenance of mouse neural stem/progenitor cells. Plos One. 8: e74315. PMID 24066135 DOI: 10.1371/journal.pone.0074315  0.72
2013 Kawai M, Ogawa Y, Shimmura S, Ohta S, Suzuki T, Kawamura N, Kuwana M, Kawakami Y, Tsubota K. Expression and localization of aging markers in lacrimal gland of chronic graft-versus-host disease. Scientific Reports. 3: 2455. PMID 23986066 DOI: 10.1038/srep02455  0.72
2013 Kudo-Saito C, Fuwa T, Murakami K, Kawakami Y. Targeting FSTL1 prevents tumor bone metastasis and consequent immune dysfunction. Cancer Research. 73: 6185-93. PMID 23966294 DOI: 10.1158/0008-5472.CAN-13-1364  0.72
2013 Qu N, Xu M, Mizoguchi I, Furusawa J, Kaneko K, Watanabe K, Mizuguchi J, Itoh M, Kawakami Y, Yoshimoto T. Pivotal roles of T-helper 17-related cytokines, IL-17, IL-22, and IL-23, in inflammatory diseases. Clinical & Developmental Immunology. 2013: 968549. PMID 23956763 DOI: 10.1155/2013/968549  0.72
2013 Tano T, Okamoto M, Kan S, Bando T, Goda H, Nakashiro K, Shimodaira S, Koido S, Homma S, Fujita T, Sato M, Yamashita N, Hamakawa H, Kawakami Y. Immunochemoradiotherapy for patients with oral squamous cell carcinoma: augmentation of OK-432-induced helper T cell 1 response by 5-FU and X-ray irradiation. Neoplasia (New York, N.Y.). 15: 805-14. PMID 23814492 DOI: 10.1593/neo.13488  0.72
2013 Yaguchi S, Ogawa Y, Shimmura S, Kawakita T, Hatou S, Satofuka S, Nakamura S, Imada T, Miyashita H, Yoshida S, Yaguchi T, Ozawa Y, Mori T, Okamoto S, Kawakami Y, et al. Angiotensin II type 1 receptor antagonist attenuates lacrimal gland, lung, and liver fibrosis in a murine model of chronic graft-versus-host disease. Plos One. 8: e64724. PMID 23762250 DOI: 10.1371/journal.pone.0064724  0.72
2013 Kawakami Y, Yaguchi T, Sumimoto H, Kudo-Saito C, Iwata-Kajihara T, Nakamura S, Tsujikawa T, Park JH, Popivanova BK, Miyazaki J, Kawamura N. Improvement of cancer immunotherapy by combining molecular targeted therapy. Frontiers in Oncology. 3: 136. PMID 23755373 DOI: 10.3389/fonc.2013.00136  0.72
2013 Kawakami Y, Yaguchi T, Sumimoto H, Kudo-Saito C, Tsukamoto N, Iwata-Kajihara T, Nakamura S, Nishio H, Satomi R, Kobayashi A, Tanaka M, Park JH, Kamijuku H, Tsujikawa T, Kawamura N. Cancer-induced immunosuppressive cascades and their reversal by molecular-targeted therapy. Annals of the New York Academy of Sciences. 1284: 80-6. PMID 23651199 DOI: 10.1111/nyas.12094  0.72
2013 Ohta S, Imaizumi Y, Akamatsu W, Okano H, Kawakami Y. Generation of human melanocytes from induced pluripotent stem cells. Methods in Molecular Biology (Clifton, N.J.). 989: 193-215. PMID 23483397 DOI: 10.1007/978-1-62703-330-5_16  0.72
2013 Tano T, Okamoto M, Kan S, Nakashiro K, Shimodaira S, Koido S, Homma S, Sato M, Fujita T, Kawakami Y, Hamakawa H. Prognostic impact of expression of Bcl-2 and Bax genes in circulating immune cells derived from patients with head and neck carcinoma. Neoplasia (New York, N.Y.). 15: 305-14. PMID 23479508 DOI: 10.1593/neo.121528  0.72
2013 Tsujikawa T, Yaguchi T, Ohmura G, Ohta S, Kobayashi A, Kawamura N, Fujita T, Nakano H, Shimada T, Takahashi T, Nakao R, Yanagisawa A, Hisa Y, Kawakami Y. Autocrine and paracrine loops between cancer cells and macrophages promote lymph node metastasis via CCR4/CCL22 in head and neck squamous cell carcinoma. International Journal of Cancer. Journal International Du Cancer. 132: 2755-66. PMID 23180648 DOI: 10.1002/ijc.27966  0.72
2013 Kudo-Saito C, Shirako H, Ohike M, Tsukamoto N, Kawakami Y. CCL2 is critical for immunosuppression to promote cancer metastasis. Clinical & Experimental Metastasis. 30: 393-405. PMID 23143679 DOI: 10.1007/s10585-012-9545-6  0.72
2013 Akagi H, Higuchi H, Sumimoto H, Igarashi T, Kabashima A, Mizuguchi H, Izumiya M, Sakai G, Adachi M, Funakoshi S, Nakamura S, Hamamoto Y, Kanai T, Takaishi H, Kawakami Y, et al. Suppression of myeloid cell leukemia-1 (Mcl-1) enhances chemotherapy-associated apoptosis in gastric cancer cells. Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 16: 100-10. PMID 22527182 DOI: 10.1007/s10120-012-0153-6  0.72
2012 Kawakami Y. [Molecular targets for development of cancer immunotherapy]. Nihon Rinsho. Japanese Journal of Clinical Medicine. 70: 144-8. PMID 23513828  0.72
2012 Kawakami Y, Matsushita M, Ueda R, Tsukamoto N, Ohta S. [Immunotherapy targeting cancer stem cells]. Nihon Rinsho. Japanese Journal of Clinical Medicine. 70: 2142-6. PMID 23259387  0.72
2012 Galon J, Pagès F, Marincola FM, Angell HK, Thurin M, Lugli A, Zlobec I, Berger A, Bifulco C, Botti G, Tatangelo F, Britten CM, Kreiter S, Chouchane L, Delrio P, ... ... Kawakami Y, et al. Cancer classification using the Immunoscore: a worldwide task force. Journal of Translational Medicine. 10: 205. PMID 23034130 DOI: 10.1186/1479-5876-10-205  0.72
2012 Kamoi M, Ogawa Y, Nakamura S, Dogru M, Nagai T, Obata H, Ito M, Kaido M, Kawakita T, Okada Y, Kawakami Y, Shimmura S, Tsubota K. Accumulation of secretory vesicles in the lacrimal gland epithelia is related to non-Sjögren's type dry eye in visual display terminal users. Plos One. 7: e43688. PMID 22962587 DOI: 10.1371/journal.pone.0043688  0.72
2012 Yaguchi T, Goto Y, Kido K, Mochimaru H, Sakurai T, Tsukamoto N, Kudo-Saito C, Fujita T, Sumimoto H, Kawakami Y. Immune suppression and resistance mediated by constitutive activation of Wnt/β-catenin signaling in human melanoma cells. Journal of Immunology (Baltimore, Md. : 1950). 189: 2110-7. PMID 22815287 DOI: 10.4049/jimmunol.1102282  0.72
2012 Yaguchi S, Ogawa Y, Shimmura S, Hatou S, Nakamura S, Inaba T, Imada T, Ozawa Y, Kawakami Y, Ishida S, Tsubota K. Presence and physiologic function of the renin-angiotensin system in mouse lacrimal gland. Investigative Ophthalmology & Visual Science. 53: 5416-25. PMID 22786901 DOI: 10.1167/iovs.12-9891  0.72
2012 Mishima K, Inoue H, Nishiyama T, Mabuchi Y, Amano Y, Ide F, Matsui M, Yamada H, Yamamoto G, Tanaka J, Yasuhara R, Sakurai T, Lee MC, Chiba K, Sumimoto H, ... Kawakami Y, et al. Transplantation of side population cells restores the function of damaged exocrine glands through clusterin. Stem Cells (Dayton, Ohio). 30: 1925-37. PMID 22782911 DOI: 10.1002/stem.1173  0.72
2012 Okabayashi K, Fujita T, Miyazaki J, Okada T, Iwata T, Hirao N, Noji S, Tsukamoto N, Goshima N, Hasegawa H, Takeuchi H, Ueda M, Kitagawa Y, Kawakami Y. Cancer-testis antigen BORIS is a novel prognostic marker for patients with esophageal cancer. Cancer Science. 103: 1617-24. PMID 22676270 DOI: 10.1111/j.1349-7006.2012.02355.x  0.72
2012 Kawakami Y, Kawase Y, Ohizumi A, Noji S, Sakurai T, Fujita T. [Biomarkers for cancer immunotherapy]. Nihon Rinsho. Japanese Journal of Clinical Medicine. 70: 759-66. PMID 22619998  0.72
2012 Ohta S, Misawa A, Fukaya R, Inoue S, Kanemura Y, Okano H, Kawakami Y, Toda M. Macrophage migration inhibitory factor (MIF) promotes cell survival and proliferation of neural stem/progenitor cells. Journal of Cell Science. 125: 3210-20. PMID 22454509 DOI: 10.1242/jcs.102210  0.72
2012 Tano T, Okamoto M, Kan S, Nakashiro K, Shimodaira S, Yamashita N, Kawakami Y, Hamakawa H. Growth inhibition and apoptosis by an active component of OK-432, a streptococcal agent, via Toll-like receptor 4 in human head and neck cancer cell lines. Oral Oncology. 48: 678-85. PMID 22387210 DOI: 10.1016/j.oraloncology.2012.02.005  0.72
2012 Shimizu T, Ishikawa T, Iwai S, Ueki A, Sugihara E, Onishi N, Kuninaka S, Miyamoto T, Toyama Y, Ijiri H, Mori H, Matsuzaki Y, Yaguchi T, Nishio H, Kawakami Y, et al. Fibroblast growth factor-2 is an important factor that maintains cellular immaturity and contributes to aggressiveness of osteosarcoma. Molecular Cancer Research : McR. 10: 454-68. PMID 22228819 DOI: 10.1158/1541-7786.MCR-11-0347  0.72
2012 Takahashi S, Fusaki N, Ohta S, Iwahori Y, Iizuka Y, Inagawa K, Kawakami Y, Yoshida K, Toda M. Downregulation of KIF23 suppresses glioma proliferation. Journal of Neuro-Oncology. 106: 519-29. PMID 21904957 DOI: 10.1007/s11060-011-0706-2  0.72
2011 Fox BA, Schendel DJ, Butterfield LH, Aamdal S, Allison JP, Ascierto PA, Atkins MB, Bartunkova J, Bergmann L, Berinstein N, Bonorino CC, Borden E, Bramson JL, Britten CM, Cao X, ... ... Kawakami Y, et al. Defining the critical hurdles in cancer immunotherapy. Journal of Translational Medicine. 9: 214. PMID 22168571 DOI: 10.1186/1479-5876-9-214  0.72
2011 Iwata-Kajihara T, Sumimoto H, Kawamura N, Ueda R, Takahashi T, Mizuguchi H, Miyagishi M, Takeda K, Kawakami Y. Enhanced cancer immunotherapy using STAT3-depleted dendritic cells with high Th1-inducing ability and resistance to cancer cell-derived inhibitory factors. Journal of Immunology (Baltimore, Md. : 1950). 187: 27-36. PMID 21632716 DOI: 10.4049/jimmunol.1002067  0.72
2011 Tabuse M, Ohta S, Ohashi Y, Fukaya R, Misawa A, Yoshida K, Kawase T, Saya H, Thirant C, Chneiweiss H, Matsuzaki Y, Okano H, Kawakami Y, Toda M. Functional analysis of HOXD9 in human gliomas and glioma cancer stem cells. Molecular Cancer. 10: 60. PMID 21600039 DOI: 10.1186/1476-4598-10-60  0.72
2011 Butterfield LH, Palucka AK, Britten CM, Dhodapkar MV, HÃ¥kansson L, Janetzki S, Kawakami Y, Kleen TO, Lee PP, Maccalli C, Maecker HT, Maino VC, Maio M, Malyguine A, Masucci G, et al. Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 3064-76. PMID 21558394 DOI: 10.1158/1078-0432.CCR-10-2234  0.72
2011 Namiki T, Tanemura A, Valencia JC, Coelho SG, Passeron T, Kawaguchi M, Vieira WD, Ishikawa M, Nishijima W, Izumo T, Kaneko Y, Katayama I, Yamaguchi Y, Yin L, Polley EC, ... ... Kawakami Y, et al. AMP kinase-related kinase NUAK2 affects tumor growth, migration, and clinical outcome of human melanoma. Proceedings of the National Academy of Sciences of the United States of America. 108: 6597-602. PMID 21460252 DOI: 10.1073/pnas.1007694108  0.72
2011 Yaguchi T, Sumimoto H, Kudo-Saito C, Tsukamoto N, Ueda R, Iwata-Kajihara T, Nishio H, Kawamura N, Kawakami Y. The mechanisms of cancer immunoescape and development of overcoming strategies. International Journal of Hematology. 93: 294-300. PMID 21374075 DOI: 10.1007/s12185-011-0799-6  0.72
2011 Ohta S, Imaizumi Y, Okada Y, Akamatsu W, Kuwahara R, Ohyama M, Amagai M, Matsuzaki Y, Yamanaka S, Okano H, Kawakami Y. Generation of human melanocytes from induced pluripotent stem cells. Plos One. 6: e16182. PMID 21249204 DOI: 10.1371/journal.pone.0016182  0.72
2011 Ohkusu-Tsukada K, Ohta S, Kawakami Y, Toda M. Adjuvant effects of formalin-inactivated HSV through activation of dendritic cells and inactivation of myeloid-derived suppressor cells in cancer immunotherapy. International Journal of Cancer. Journal International Du Cancer. 128: 119-31. PMID 20232389 DOI: 10.1002/ijc.25319  0.72
2010 Baba T, Sato-Matsushita M, Kanamoto A, Itoh A, Oyaizu N, Inoue Y, Kawakami Y, Tahara H. Phase I clinical trial of the vaccination for the patients with metastatic melanoma using gp100-derived epitope peptide restricted to HLA-A*2402. Journal of Translational Medicine. 8: 84. PMID 20843377 DOI: 10.1186/1479-5876-8-84  0.72
2010 Kawakami Y. [Cancer treatment by comprehensive regulation of anti-tumor immune network]. Nihon Rinsho. Japanese Journal of Clinical Medicine. 68: 1094-9. PMID 20535961  0.72
2010 Sumimoto H, Kawakami Y. The RNA silencing technology applied by lentiviral vectors in oncology. Methods in Molecular Biology (Clifton, N.J.). 614: 187-99. PMID 20225045 DOI: 10.1007/978-1-60761-533-0_13  0.72
2010 Ohkusu-Tsukada K, Toda M, Udono H, Kawakami Y, Takahashi K. Targeted inhibition of IL-10-secreting CD25- Treg via p38 MAPK suppression in cancer immunotherapy. European Journal of Immunology. 40: 1011-21. PMID 20127675 DOI: 10.1002/eji.200939513  0.72
2010 Fukaya R, Ohta S, Yamaguchi M, Fujii H, Kawakami Y, Kawase T, Toda M. Isolation of cancer stem-like cells from a side population of a human glioblastoma cell line, SK-MG-1. Cancer Letters. 291: 150-7. PMID 19913993 DOI: 10.1016/j.canlet.2009.10.010  0.72
2010 Ueda R, Ohkusu-Tsukada K, Fusaki N, Soeda A, Kawase T, Kawakami Y, Toda M. Identification of HLA-A2- and A24-restricted T-cell epitopes derived from SOX6 expressed in glioma stem cells for immunotherapy. International Journal of Cancer. Journal International Du Cancer. 126: 919-29. PMID 19728337 DOI: 10.1002/ijc.24851  0.72
2010 Goto Y, Koyanagi K, Narita N, Kawakami Y, Takata M, Uchiyama A, Nguyen L, Nguyen T, Ye X, Morton DL, Hoon DS. Aberrant fatty acid-binding protein-7 gene expression in cutaneous malignant melanoma. The Journal of Investigative Dermatology. 130: 221-9. PMID 19587692 DOI: 10.1038/jid.2009.195  0.72
2009 Ogawa Y, Shimmura S, Kawakita T, Yoshida S, Kawakami Y, Tsubota K. Epithelial mesenchymal transition in human ocular chronic graft-versus-host disease. The American Journal of Pathology. 175: 2372-81. PMID 19893038 DOI: 10.2353/ajpath.2009.090318  0.72
2009 Tsukamoto N, Okada S, Onami Y, Sasaki Y, Umezawa K, Kawakami Y. Impairment of plasmacytoid dendritic cells for IFN production by the ligand for immunoglobulin-like transcript 7 expressed on human cancer cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 5733-43. PMID 19723650 DOI: 10.1158/1078-0432.CCR-09-0171  0.72
2009 Kido K, Sumimoto H, Asada S, Okada SM, Yaguchi T, Kawamura N, Miyagishi M, Saida T, Kawakami Y. Simultaneous suppression of MITF and BRAF V600E enhanced inhibition of melanoma cell proliferation. Cancer Science. 100: 1863-9. PMID 19659611 DOI: 10.1111/j.1349-7006.2009.01266.x  0.72
2009 Sato S, Hoshino K, Satoh T, Fujita T, Kawakami Y, Fujita T, Kuwana M. RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease. Arthritis and Rheumatism. 60: 2193-200. PMID 19565506 DOI: 10.1002/art.24621  0.72
2009 Tahara H, Sato M, Thurin M, Wang E, Butterfield LH, Disis ML, Fox BA, Lee PP, Khleif SN, Wigginton JM, Ambs S, Akutsu Y, Chaussabel D, Doki Y, Eremin O, ... ... Kawakami Y, et al. Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology. Journal of Translational Medicine. 7: 45. PMID 19534815 DOI: 10.1186/1479-5876-7-45  0.72
2009 Hayashi K, Ohta S, Kawakami Y, Toda M. Activation of dendritic-like cells and neural stem/progenitor cells in injured spinal cord by GM-CSF. Neuroscience Research. 64: 96-103. PMID 19428687 DOI: 10.1016/j.neures.2009.01.018  0.72
2009 Mochimaru H, Takahashi E, Tsukamoto N, Miyazaki J, Yaguchi T, Koto T, Kurihara T, Noda K, Ozawa Y, Ishimoto T, Kawakami Y, Tanihara H, Saya H, Ishida S, Tsubota K. Involvement of hyaluronan and its receptor CD44 with choroidal neovascularization. Investigative Ophthalmology & Visual Science. 50: 4410-5. PMID 19339747 DOI: 10.1167/iovs.08-3044  0.72
2009 Kudo-Saito C, Shirako H, Takeuchi T, Kawakami Y. Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. Cancer Cell. 15: 195-206. PMID 19249678 DOI: 10.1016/j.ccr.2009.01.023  0.72
2008 Li Z, Oka Y, Tsuboi A, Fujiki F, Harada Y, Nakajima H, Masuda T, Fukuda Y, Kawakatsu M, Morimoto S, Katagiri T, Tatsumi N, Hosen N, Shirakata T, Nishida S, ... Kawakami Y, et al. Identification of a WT1 protein-derived peptide, WT1, as a HLA-A 0206-restricted, WT1-specific CTL epitope. Microbiology and Immunology. 52: 551-8. PMID 19090835 DOI: 10.1111/j.1348-0421.2008.00069.x  0.72
2008 Matsumoto K, Kubo H, Murata H, Uhara H, Takata M, Shibata S, Yasue S, Sakakibara A, Tomita Y, Kageshita T, Kawakami Y, Mizuno M, Yoshida J, Saida T. A pilot study of human interferon beta gene therapy for patients with advanced melanoma by in vivo transduction using cationic liposomes. Japanese Journal of Clinical Oncology. 38: 849-56. PMID 18945721 DOI: 10.1093/jjco/hyn114  0.72
2008 Seta N, Tajima M, Kobayashi S, Kawakami Y, Hashimoto H, Kuwana M. Autoreactive T-cell responses to myeloperoxidase in patients with antineutrophil cytoplasmic antibody-associated vasculitis and in healthy individuals. Modern Rheumatology / the Japan Rheumatism Association. 18: 593-600. PMID 18806928 DOI: 10.1007/s10165-008-0109-1  0.72
2008 Asahi A, Nishimoto T, Okazaki Y, Suzuki H, Masaoka T, Kawakami Y, Ikeda Y, Kuwana M. Helicobacter pylori eradication shifts monocyte Fcgamma receptor balance toward inhibitory FcgammaRIIB in immune thrombocytopenic purpura patients. The Journal of Clinical Investigation. 118: 2939-49. PMID 18654664 DOI: 10.1172/JCI34496  0.72
2008 Takahashi H, Amagai M, Nishikawa T, Fujii Y, Kawakami Y, Kuwana M. Novel system evaluating in vivo pathogenicity of desmoglein 3-reactive T cell clones using murine pemphigus vulgaris. Journal of Immunology (Baltimore, Md. : 1950). 181: 1526-35. PMID 18606708  0.72
2008 Yaguchi M, Ohta S, Toyama Y, Kawakami Y, Toda M. Functional recovery after spinal cord injury in mice through activation of microglia and dendritic cells after IL-12 administration. Journal of Neuroscience Research. 86: 1972-80. PMID 18438913 DOI: 10.1002/jnr.21658  0.72
2008 Mochimaru H, Usui T, Yaguchi T, Nagahama Y, Hasegawa G, Usui Y, Shimmura S, Tsubota K, Amano S, Kawakami Y, Ishida S. Suppression of alkali burn-induced corneal neovascularization by dendritic cell vaccination targeting VEGF receptor 2. Investigative Ophthalmology & Visual Science. 49: 2172-7. PMID 18263815 DOI: 10.1167/iovs.07-1396  0.72
2008 Ueda R, Kinoshita E, Ito R, Kawase T, Kawakami Y, Toda M. Induction of protective and therapeutic antitumor immunity by a DNA vaccine with a glioma antigen, SOX6. International Journal of Cancer. Journal International Du Cancer. 122: 2274-9. PMID 18224680 DOI: 10.1002/ijc.23366  0.72
2008 Ohta S, Ueda Y, Yaguchi M, Matsuzaki Y, Nakamura M, Toyama Y, Tanioka Y, Tamaoki N, Nomura T, Okano H, Kawakami Y, Toda M. Isolation and characterization of dendritic cells from common marmosets for preclinical cell therapy studies. Immunology. 123: 566-74. PMID 18005037 DOI: 10.1111/j.1365-2567.2007.02727.x  0.72
2007 Sumimoto H, Kawakami Y. Lentiviral vector-mediated RNAi and its use for cancer research. Future Oncology (London, England). 3: 655-64. PMID 18041918 DOI: 10.2217/14796694.3.6.655  0.72
2006 Iizuka Y, Kojima H, Kobata T, Kawase T, Kawakami Y, Toda M. Identification of a glioma antigen, GARC-1, using cytotoxic T lymphocytes induced by HSV cancer vaccine. International Journal of Cancer. Journal International Du Cancer. 118: 942-9. PMID 16152596 DOI: 10.1002/ijc.21432  0.72
2004 Ohashi Y, Ueda M, Kawase T, Kawakami Y, Toda M. Identification of an epigenetically silenced gene, RFX1, in human glioma cells using restriction landmark genomic scanning. Oncogene. 23: 7772-9. PMID 15334059 DOI: 10.1038/sj.onc.1208058  0.72
2004 Iizuka Y, Suzuki A, Kawakami Y, Toda M. Augmentation of antitumor immune responses by multiple intratumoral inoculations of replication-conditional HSV and interleukin-12. Journal of Immunotherapy (Hagerstown, Md. : 1997). 27: 92-8. PMID 14770080  0.72
2004 Ueda R, Iizuka Y, Yoshida K, Kawase T, Kawakami Y, Toda M. Identification of a human glioma antigen, SOX6, recognized by patients' sera. Oncogene. 23: 1420-7. PMID 14691456 DOI: 10.1038/sj.onc.1207252  0.72
2002 Toda M, Iizuka Y, Kawase T, Uyemura K, Kawakami Y. Immuno-viral therapy of brain tumors by combination of viral therapy with cancer vaccination using a replication-conditional HSV. Cancer Gene Therapy. 9: 356-64. PMID 11960286 DOI: 10.1038/sj.cgt.7700446  0.72
2002 Endo T, Toda M, Watanabe M, Iizuka Y, Kubota T, Kitajima M, Kawakami Y. In situ cancer vaccination with a replication-conditional HSV for the treatment of liver metastasis of colon cancer. Cancer Gene Therapy. 9: 142-8. PMID 11857031 DOI: 10.1038/sj.cgt.7700407  0.72
Show low-probability matches.